Biogen Profit Margin 2006-2021 | BIIB
Current and historical gross margin, operating margin and net profit margin for Biogen (BIIB) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Biogen net profit margin as of September 30, 2021 is 13.93%.
|Biogen Annual Profit Margins
|Biogen Quarterly Profit Margins
||Medical - Biomedical and Genetics
Biogen is a leading biopharmaceutical company engaged in the research, development and marketing of targeted therapies for the treatment of cancer, autoimmune and inflammatory diseases. The company owns industry leading brands for the treatment of multiple sclerosis, next-generation treatments for hemophilia, and a deep clinical pipeline ranging from Alzheimer's disease, lupus nephritis to neuropathic pain.